{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T14:51:47Z","timestamp":1792853507511,"version":"4.5.0"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,19]],"date-time":"2026-04-19T00:00:00Z","timestamp":1776556800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100019018","name":"CAMS Innovation Fund for Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100019018","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82173332"],"award-info":[{"award-number":["82173332"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017610","name":"Shenzhen Science and Technology Innovation Program","doi-asserted-by":"publisher","award":["JCYJ20210324125408022"],"award-info":[{"award-number":["JCYJ20210324125408022"]}],"id":[{"id":"10.13039\/501100017610","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2022YFC3401000"],"award-info":[{"award-number":["2022YFC3401000"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Redox Biology"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.redox.2026.104179","type":"journal-article","created":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T16:19:37Z","timestamp":1776701977000},"page":"104179","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Redox-triggered USP18 confers cisplatin resistance in ovarian cancer by selectively activating a non-canonical FSP1-dependent ferroptosis escape pathway"],"prefix":"10.1016","volume":"93","author":[{"given":"Zitong","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ge","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Menghan","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liying","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongdong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7789-0158","authenticated-orcid":false,"given":"Yongmei","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.redox.2026.104179_bib1","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"issue":"4","key":"10.1016\/j.redox.2026.104179_bib2","first-page":"284","article-title":"Ovarian cancer statistics, 2018","volume":"68","author":"Torre","year":"2018","journal-title":"CA Cancer J. Clin."},{"issue":"1","key":"10.1016\/j.redox.2026.104179_bib3","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1002\/path.4230","article-title":"Distinct evolutionary trajectories of primary high-grade serous ovarian cancers revealed through spatial mutational profiling","volume":"231","author":"Bashashati","year":"2013","journal-title":"J. Pathol."},{"issue":"12","key":"10.1016\/j.redox.2026.104179_bib4","article-title":"Comparison of the efficacy of Cisplatin\/Paclitaxel versus Carboplatin\/Paclitaxel in improving survival and quality of life in the advanced ovarian cancer patient population: a systematic review and meta-analysis of randomized control trials","volume":"15","author":"Mansoor","year":"2023","journal-title":"Cureus"},{"key":"10.1016\/j.redox.2026.104179_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s44178-023-00068-3","article-title":"Recent advances in the treatment for gynecologic oncology","volume":"3","author":"Li","year":"2024","journal-title":"Holistic Integrat. Oncol."},{"issue":"14","key":"10.1016\/j.redox.2026.104179_bib6","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1001\/jama.2025.9495","article-title":"Ovarian cancer: a review","volume":"334","author":"Caruso","year":"2025","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.redox.2026.104179_bib7","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.intonc.2025.02.001","article-title":"Artificial intelligence in tumor drug resistance: mechanisms and treatment prospects","volume":"1","author":"Gu","year":"2025","journal-title":"Intell. Oncol."},{"issue":"8064","key":"10.1016\/j.redox.2026.104179_bib8","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1038\/s41586-025-08756-y","article-title":"Oxidation of retromer complex controls mitochondrial translation","volume":"641","author":"Zhang","year":"2025","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.redox.2026.104179_bib9","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1038\/s41568-021-00435-0","article-title":"The role of ROS in tumour development and progression","volume":"22","author":"Cheung","year":"2022","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.redox.2026.104179_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2025.103787","article-title":"Decoding Parkinson's disease: the interplay of cell death pathways, oxidative stress, and therapeutic innovations","volume":"85","author":"Liu","year":"2025","journal-title":"Redox Biol."},{"issue":"8","key":"10.1016\/j.redox.2026.104179_bib11","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/s41573-024-00979-4","article-title":"Targeting ROS in cancer: rationale and strategies","volume":"23","author":"Glorieux","year":"2024","journal-title":"Nat. Rev. Drug Discov."},{"issue":"7","key":"10.1016\/j.redox.2026.104179_bib12","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/s41568-022-00459-0","article-title":"Targeting ferroptosis as a vulnerability in cancer","volume":"22","author":"Lei","year":"2022","journal-title":"Nat. Rev. Cancer"},{"issue":"4","key":"10.1016\/j.redox.2026.104179_bib13","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1038\/s41580-020-00324-8","article-title":"Ferroptosis: mechanisms, biology and role in disease","volume":"22","author":"Jiang","year":"2021","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"1\u20132","key":"10.1016\/j.redox.2026.104179_bib14","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.cell.2013.12.010","article-title":"Regulation of ferroptotic cancer cell death by GPX4","volume":"156","author":"Yang","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.redox.2026.104179_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2022.100916","article-title":"Overcoming cancer chemotherapy resistance by the induction of ferroptosis","volume":"66","author":"Wang","year":"2023","journal-title":"Drug Resist. Updates"},{"issue":"1","key":"10.1016\/j.redox.2026.104179_bib16","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s12943-022-01530-y","article-title":"Ferroptosis in cancer therapy: a novel approach to reversing drug resistance","volume":"21","author":"Zhang","year":"2022","journal-title":"Mol. Cancer"},{"issue":"16","key":"10.1016\/j.redox.2026.104179_bib17","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2315541121","article-title":"USP8-governed GPX4 homeostasis orchestrates ferroptosis and cancer immunotherapy","volume":"121","author":"Li","year":"2024","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"45","key":"10.1016\/j.redox.2026.104179_bib18","article-title":"Deubiquitylase USP52 promotes bladder cancer progression by modulating ferroptosis through stabilizing SLC7A11\/xCT","volume":"11","author":"Liu","year":"2024","journal-title":"Adv. Sci. (Weinh.)"},{"issue":"33","key":"10.1016\/j.redox.2026.104179_bib19","article-title":"Targeting USP8 inhibits O-GlcNAcylation of SLC7A11 to promote ferroptosis of hepatocellular carcinoma via stabilization of OGT","volume":"10","author":"Tang","year":"2023","journal-title":"Adv. Sci. (Weinh.)"},{"issue":"28","key":"10.1016\/j.redox.2026.104179_bib20","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2320655121","article-title":"The CRL3(KCTD10) ubiquitin ligase-USP18 axis coordinately regulates cystine uptake and ferroptosis by modulating SLC7A11","volume":"121","author":"Zhou","year":"2024","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.redox.2026.104179_bib21","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.bbrc.2022.01.020","article-title":"The USP18-FBXO6 axis maintains the malignancy of ovarian cancer","volume":"593","author":"Li","year":"2022","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"2","key":"10.1016\/j.redox.2026.104179_bib22","first-page":"417","article-title":"USP18 contributes to the proliferation and migration of ovarian cancer cells by regulating the AKT\/mTOR signaling pathway","volume":"69","author":"Liu","year":"2022","journal-title":"Acta Biochim. Pol."},{"issue":"8","key":"10.1016\/j.redox.2026.104179_bib23","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1002\/cbin.12028","article-title":"UBP43 promotes epithelial ovarian carcinogenesis via activation of beta-catenin signaling pathway","volume":"47","author":"Xie","year":"2023","journal-title":"Cell Biol. Int."},{"issue":"3","key":"10.1016\/j.redox.2026.104179_bib24","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1158\/0008-5472.CAN-17-1752","article-title":"Evidence for the ISG15-Specific deubiquitinase USP18 as an antineoplastic target","volume":"78","author":"Mustachio","year":"2018","journal-title":"Cancer Res."},{"issue":"12","key":"10.1016\/j.redox.2026.104179_bib25","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1038\/cr.2016.125","article-title":"USP18 recruits USP20 to promote innate antiviral response through deubiquitinating STING\/MITA","volume":"26","author":"Zhang","year":"2016","journal-title":"Cell Res."},{"key":"10.1016\/j.redox.2026.104179_bib26","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1162786","article-title":"Transcriptomic analyses of ovarian clear-cell carcinoma with concurrent endometriosis","volume":"14","author":"Collins","year":"2023","journal-title":"Front. Endocrinol."},{"issue":"1","key":"10.1016\/j.redox.2026.104179_bib27","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1186\/s13073-021-00952-5","article-title":"Distinct transcriptional programs stratify ovarian cancer cell lines into the five major histological subtypes","volume":"13","author":"Barnes","year":"2021","journal-title":"Genome Med."},{"issue":"7498","key":"10.1016\/j.redox.2026.104179_bib28","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/nature13176","article-title":"Identification of genomic alterations in oesophageal squamous cell cancer","volume":"509","author":"Song","year":"2014","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.redox.2026.104179_bib29","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1158\/0008-5472.CAN-09-1947","article-title":"Drug combination studies and their synergy quantification using the Chou-Talalay method","volume":"70","author":"Chou","year":"2010","journal-title":"Cancer Res."},{"issue":"3","key":"10.1016\/j.redox.2026.104179_bib30","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.bbrc.2019.04.011","article-title":"ROS\/JNK\/c-Jun axis is involved in oridonin-induced caspase-dependent apoptosis in human colorectal cancer cells","volume":"513","author":"Zhang","year":"2019","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"4973","key":"10.1016\/j.redox.2026.104179_bib31","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1126\/science.2118682","article-title":"Redox regulation of fos and Jun DNA-binding activity in vitro","volume":"249","author":"Abate","year":"1990","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.redox.2026.104179_bib32","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S0092-8674(00)81999-6","article-title":"c-Jun can recruit JNK to phosphorylate dimerization partners via specific docking interactions","volume":"87","author":"Kallunki","year":"1996","journal-title":"Cell"},{"issue":"14","key":"10.1016\/j.redox.2026.104179_bib33","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1038\/onc.2011.369","article-title":"Rack1 protects N-terminal phosphorylated c-Jun from Fbw7-mediated degradation","volume":"31","author":"Zhang","year":"2012","journal-title":"Oncogene"},{"key":"10.1016\/j.redox.2026.104179_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2019.101328","article-title":"Insight into the mechanism of ferroptosis inhibition by ferrostatin-1","volume":"28","author":"Miotto","year":"2020","journal-title":"Redox Biol."},{"issue":"1","key":"10.1016\/j.redox.2026.104179_bib35","article-title":"IGF2BP2 drives cell cycle progression in triple-negative breast cancer by recruiting EIF4A1 to promote the m6A-Modified CDK6 translation initiation process","volume":"11","author":"Xia","year":"2024","journal-title":"Adv. Sci. (Weinh.)"},{"issue":"3","key":"10.1016\/j.redox.2026.104179_bib36","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/s41556-018-0045-z","article-title":"Recognition of RNA N(6)-methyladenosine by IGF2BP proteins enhances mRNA stability and translation","volume":"20","author":"Huang","year":"2018","journal-title":"Nat. Cell Biol."},{"issue":"4","key":"10.1016\/j.redox.2026.104179_bib37","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/s41571-023-00736-3","article-title":"Protein degraders enter the clinic - a new approach to cancer therapy","volume":"20","author":"Chirnomas","year":"2023","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"7","key":"10.1016\/j.redox.2026.104179_bib38","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/s41568-025-00817-8","article-title":"Targeted protein degradation for cancer therapy","volume":"25","author":"Hinterndorfer","year":"2025","journal-title":"Nat. Rev. Cancer"},{"issue":"1","key":"10.1016\/j.redox.2026.104179_bib39","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1186\/s12943-024-02046-3","article-title":"Ubiquitination and deubiquitination in cancer: from mechanisms to novel therapeutic approaches","volume":"23","author":"Liu","year":"2024","journal-title":"Mol. Cancer"},{"issue":"7784","key":"10.1016\/j.redox.2026.104179_bib40","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1038\/s41586-019-1705-2","article-title":"The CoQ oxidoreductase FSP1 acts parallel to GPX4 to inhibit ferroptosis","volume":"575","author":"Bersuker","year":"2019","journal-title":"Nature"},{"issue":"14","key":"10.1016\/j.redox.2026.104179_bib41","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1016\/j.cell.2022.06.003","article-title":"Ferroptosis turns 10: emerging mechanisms, physiological functions, and therapeutic applications","volume":"185","author":"Stockwell","year":"2022","journal-title":"Cell"},{"issue":"9","key":"10.1016\/j.redox.2026.104179_bib42","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/s41571-020-0377-z","article-title":"MET-dependent solid tumours - molecular diagnosis and targeted therapy","volume":"17","author":"Guo","year":"2020","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.redox.2026.104179_bib43","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.semcancer.2022.04.002","article-title":"EGFR signaling pathway as therapeutic target in human cancers","volume":"85","author":"Levantini","year":"2022","journal-title":"Semin. Cancer Biol."},{"issue":"2","key":"10.1016\/j.redox.2026.104179_bib44","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/s41573-022-00579-0","article-title":"Targeting HER2-positive breast cancer: advances and future directions","volume":"22","author":"Swain","year":"2023","journal-title":"Nat. Rev. Drug Discov."},{"issue":"1","key":"10.1016\/j.redox.2026.104179_bib45","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1186\/s13046-021-02130-2","article-title":"Resistance to anti-EGFR therapies in metastatic colorectal cancer: underlying mechanisms and reversal strategies","volume":"40","author":"Zhou","year":"2021","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"7784","key":"10.1016\/j.redox.2026.104179_bib46","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/s41586-019-1707-0","article-title":"FSP1 is a glutathione-independent ferroptosis suppressor","volume":"575","author":"Doll","year":"2019","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.redox.2026.104179_bib47","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1038\/s41556-025-01790-y","article-title":"FSP1-mediated lipid droplet quality control prevents neutral lipid peroxidation and ferroptosis","volume":"27","author":"Lange","year":"2025","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.redox.2026.104179_bib48","article-title":"Lymph node environment drives FSP1 targetability in metastasizing melanoma","author":"Palma","year":"2025","journal-title":"Nature"},{"key":"10.1016\/j.redox.2026.104179_bib49","article-title":"Targeting FSP1 triggers ferroptosis in lung cancer","author":"Wu","year":"2025","journal-title":"Nature"},{"issue":"7969","key":"10.1016\/j.redox.2026.104179_bib50","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/s41586-023-06255-6","article-title":"Phase separation of FSP1 promotes ferroptosis","volume":"619","author":"Nakamura","year":"2023","journal-title":"Nature"}],"container-title":["Redox Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213231726001771?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213231726001771?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T22:02:25Z","timestamp":1783202545000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213231726001771"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":50,"alternative-id":["S2213231726001771"],"URL":"https:\/\/doi.org\/10.1016\/j.redox.2026.104179","relation":{},"ISSN":["2213-2317"],"issn-type":[{"value":"2213-2317","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Redox-triggered USP18 confers cisplatin resistance in ovarian cancer by selectively activating a non-canonical FSP1-dependent ferroptosis escape pathway","name":"articletitle","label":"Article Title"},{"value":"Redox Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.redox.2026.104179","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"104179"}}